MedKoo Cat#: 564186 | Name: SGC-GAK-1
Featured

Description:

WARNING: This product is for research use only, not for human or veterinary use.

SGC-GAK-1 is a potent and selective GAK kinase probe which targets the ATP-binding site.

Chemical Structure

SGC-GAK-1
SGC-GAK-1
CAS#2226517-76-4

Theoretical Analysis

MedKoo Cat#: 564186

Name: SGC-GAK-1

CAS#: 2226517-76-4

Chemical Formula: C18H17BrN2O3

Exact Mass: 388.0423

Molecular Weight: 389.25

Elemental Analysis: C, 55.54; H, 4.40; Br, 20.53; N, 7.20; O, 12.33

Price and Availability

Size Price Availability Quantity
10mg USD 250.00 2 Weeks
25mg USD 450.00 2 Weeks
50mg USD 700.00 2 Weeks
200mg USD 1,650.00 2 Weeks
500mg USD 2,250.00 2 Weeks
1g USD 3,250.00 2 Weeks
2g USD 5,850.00 2 Weeks
Show More
Bulk Inquiry
Buy Now
Add to Cart
Related CAS #
No Data
Synonym
SGCGAK1; SGC GAK 1; SGC-GAK-1; SGCGAK-1; SGC-GAK1
IUPAC/Chemical Name
6-Bromo-N-(3,4,5-trimethoxyphenyl)quinolin-4-amine
InChi Key
AUOSKLDNVNGKRR-UHFFFAOYSA-N
InChi Code
InChI=1S/C18H17BrN2O3/c1-22-16-9-12(10-17(23-2)18(16)24-3)21-15-6-7-20-14-5-4-11(19)8-13(14)15/h4-10H,1-3H3,(H,20,21)
SMILES Code
COC1=C(OC)C(OC)=CC(NC2=CC=NC3=CC=C(Br)C=C23)=C1
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO and ethanol
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.03.00
More Info
Product Data
Biological target:
SGC-GAK-1 is a high affinity GAK inhibitor (Kd = 1.9 nM) and exhibits >30-fold selectivity for GAK over a panel of other kinases. SGC-GAK-1 inhibits GAK in live cell assays (IC50 = 110 nM).
In vitro activity:
GAK may be physiologically involved in normal neuronal development, and decreased GAK function and the resulting impaired neurite outgrowth and synaptogenesis may be related to neurodevelopmental disorders. SGC-GAK-1 treatment of cultured neurons reduced neurite length and decreased synapse number and phosphorylation of neurofilament 200-kDa subunits relative to the control. I Reference: Mol Brain. 2022 Jul 26;15(1):68. https://pubmed.ncbi.nlm.nih.gov/35883152/
In vivo activity:
To be determined
Solvent mg/mL mM comments
Solubility
DMSO 38.9 100.00
Ethanol 19.5 50.00
Note: There can be variations in solubility for the same chemical from different vendors or different batches from the same vendor. The following factors can affect the solubility of the same chemical: solvent used for crystallization, residual solvent content, polymorphism, salt versus free form, degree of hydration, solvent temperature. Please use the solubility data as a reference only. Warming and sonication will facilitate dissolving. Still have questions? Please contact our Technical Support scientists.

Preparing Stock Solutions

The following data is based on the product molecular weight 389.25 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol:
1. Egawa J, Arta RK, Lemmon VP, Muños-Barrero M, Shi Y, Igarashi M, Someya T. The cyclin G-associated kinase (GAK) inhibitor SGC-GAK-1 inhibits neurite outgrowth and synapse formation. Mol Brain. 2022 Jul 26;15(1):68. doi: 10.1186/s13041-022-00951-6. PMID: 35883152; PMCID: PMC9327206.
In vitro protocol:
1. Egawa J, Arta RK, Lemmon VP, Muños-Barrero M, Shi Y, Igarashi M, Someya T. The cyclin G-associated kinase (GAK) inhibitor SGC-GAK-1 inhibits neurite outgrowth and synapse formation. Mol Brain. 2022 Jul 26;15(1):68. doi: 10.1186/s13041-022-00951-6. PMID: 35883152; PMCID: PMC9327206.
In vivo protocol:
To be determined